Navigation Links
IRIDEX to Present at 2014 Wedbush Life Sciences Management Access Conference
Date:8/5/2014

MOUNTAIN VIEW, Calif., Aug. 5, 2014 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that President and CEO Will Moore is scheduled to make an investor presentation at the 2014 Wedbush Life Sciences Management Access Conference at 1:55 p.m. Eastern Time on Tuesday, August 12, in New York City. In addition, Mr. Moore will participate on a panel at the conference discussing Ophthalmology Treatments & Tools at 11:30 a.m. Eastern Time on Tuesday, August 12th.

A live audio webcast of the investor presentation will be available in the Investors section of the IRIDEX website at http://www.iridex.com/.

About IRIDEX

IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through both direct and independent sales forces and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries. For further information, visit the Company's website at http://www.iridex.com.


'/>"/>
SOURCE IRIDEX Corporation
Copyright©2014 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. IRIDEX Reports 2014 Second Quarter, Six-Month Results
2. IRIDEX Announces Second Quarter 2014 Conference Call and Release Date
3. IRIDEX To Introduce Four New Products At Annual AAO Meeting
4. IRIDEX Promotes Timothy D. Buckley to Vice President of Marketing and North American Sales
5. IRIDEX Reports 2013 Third Quarter Results
6. IRIDEX Announces Third Quarter 2013 Conference Call and Release Date
7. IRIDEX to Present at Craig-Hallum 4th Annual Alpha Select Conference
8. IRIDEX to Present at 2013 Wedbush Securities Life Sciences Management Access Conference
9. IRIDEX Reports 2013 Second Quarter Results; $9.2 Million Record Q2 Revenue
10. IRIDEX Announces Second Quarter 2013 Conference Call and Release Date
11. IRIDEX Announces Automatic Conversion of Series A Preferred Stock to Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015 Amgen (NASDAQ: AMGN ... Authorization Application (MAA) to the European Medicines Agency ... AMG 416) for the treatment of secondary hyperparathyroidism ... (CKD) on hemodialysis therapy. If approved, etelcalcetide will ... administered intravenously. Etelcalcetide is a novel ...
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ... the "An Introduction to Medical Device Software: ... 2015)" conference to their offering. ... to the regulations and requirements that apply to ... interactive, using real life examples and state-of- the-art ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/6x789c/new_eu ) has announced ... (London, UK - November 16-17, 2015)" conference to ... modules concerning Pharmacovigilance are a major departure in terms ... Europe . The intention of the course is ... how they overlap and fit together and what Companies ...
Breaking Medicine Technology:Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 2Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 3Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 4Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 5Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 6Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 7An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2
... , BATESVILLE, Ind. , Feb. 3 ... versus prior year , Reported diluted earnings per ... and reported earnings per share of $0.23 in the prior year ... prior year , Company updates annual guidance for ...
... , PITTSBURGH , Feb. 3 ... patients and doctors work together to fight cancer.  Now, drug ... results which can help to determine individual cancer treatment plans ... produced by Precision Therapeutics, Inc., a life sciences company in ...
Cached Medicine Technology:Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 2Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 3Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 4Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 5Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 6Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 7Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 8Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 9Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 10Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 11Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 12Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 13Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 14Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 15Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 16Patients, Physicians Rely on ChemoFx(R) to Support Their Cancer Treatment Decisions 2Patients, Physicians Rely on ChemoFx(R) to Support Their Cancer Treatment Decisions 3
(Date:9/3/2015)... ... 2015 , ... Global Vision , the world leader in the development ... print and artwork inspection solutions, ScanProof and ArtProof at Packaging Innovations 2015. ... London, booth #F33 , Be the first to get a sneak peek of Intelligent ...
(Date:9/3/2015)... Philadelphia (PRWEB) , ... September ... ... global provider of high-quality patient safety and efficacy endpoint data collection, cloud ... Annual European PRO and eCOA Congress in Lisbon, Portugal, September 22-24, 2015. ...
(Date:9/3/2015)... ... ... “Love in Tokyo” an independent romantic comedy film by Michael Solton was ... will be released on DVD early next year, by Maverick Entertainment. The film stars ... singer/songwriter, and Jason London, lead from “Dazed and Confused.” , “Love in Tokyo” ...
(Date:9/3/2015)... ... , ... When looking at the types of people who have a hard time gaining ... have a weak appetite or those that have a fast metabolism. In order to help ... Gainer gives three tips for slowing down metabolism. , The first thing to do is ...
(Date:9/3/2015)... ... 2015 , ... Doctor Kayode Sotonwa can be counted on time ... on internal medicine keeps patients happy and healthy, something that is important to everyone. ... season, but even more so in the fall, when holiday eating and seasonal illnesses ...
Breaking Medicine News(10 mins):Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 3Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2
... ... by YHC magazine on April 25. , ... (Vocus) April 10, 2010 -- The Khanna institute to attend the YHC Health ... Village, CA 91361, , , , ,Khanna Institute of LASIK & Refractive surgery, an eye ...
... and non-sensitive folks process input differently , SATURDAY, ... the world around them in a different way, introverted ... stimuli than other people, according to a new study. ... an inborn trait that can be seen in children ...
... ... new website that highlights the practice’s state-of-the-art treatments and gentle, personalized approach. Drs. Bradley A. ... engaging look at all the practice has to offer. , ... San Diego, CA (Vocus) April 10, 2010 -- Two ...
... ... trainers in the state, Dr. Jeffrey Raval has pioneered a new process to make the ... injectable fillers, a practice that the FDA approved in 2009. , ... Denver, Colo. (PRWEB) April 10, 2010 -- As an ...
... ... , ... April 9, 2010 -- Three months on from one of the worst disasters ever witnessed, ... , , ,The international disaster relief charity has now delivered over 13,000 ShelterBoxes to ...
... ... presented by psychologist Paul G. Swingle, illustrates the use of neurotherapy in treating patients ... ADD, ADHD, epilepsy, stroke, learning disorders, traumatic brain injury, depression, fibromyalgia, and autistic spectrum ... ...
Cached Medicine News:Health News:Khanna Institute of Vision and Your Health Connection Spring Expo 2Health News:Khanna Institute of Vision and Your Health Connection Spring Expo 3Health News:Shyness May Be Rooted in Brain Processing 2Health News:San Diego Cosmetic Dentists Launch New Website and Rejuvenate Online Image 2Health News:San Diego Cosmetic Dentists Launch New Website and Rejuvenate Online Image 3Health News:Dr. Jeffrey Raval Pioneers New Method for Filler Facelifts 2Health News:Dr. Jeffrey Raval Pioneers New Method for Filler Facelifts 3Health News:Thousands More ShelterBoxes to be Sent to Haiti 2Health News:Thousands More ShelterBoxes to be Sent to Haiti 3Health News:Psychologist and Author Paul G. Swingle Talks about his Approach to Treating Depression and Mood Disorders in Online Forum 2Health News:Psychologist and Author Paul G. Swingle Talks about his Approach to Treating Depression and Mood Disorders in Online Forum 3
Look to the intuitive iLab System to deliver the best IVUS image quickly and easily. This easy-to-use installed system with tableside controller is the Clear Choice for IVUS....
... full picture ,CardioPAL SAVI is the ... cial Intelligence, with a smart algorithm running ... on each device. The Diogenes algorithm continuously ... rate, rhythm, morphology, and p-wave abnormalities ...
A patient care system tailored to your specific needs that supports current and previous-generation ICDs and pacemakers....
The Rio Catheter is designed to simplify your intravascular interventions by removing thrombus and restoring epicardial flow to the procedure....
Medicine Products: